Skip to main content

Table 3 Efficacy (proportion of patients cured) in the study groups

From: Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials

Per lesion

Cryotherapy N = 327 (Protocol)

Control N = 257 (Protocol)

Özgöztaslis O [19]

93 (53/57)

69.7 (23/33)a

Gurei M [22]

78 (47/60)

92 (67/73)b

Asilian A [21]

57.2 (120/210)

55.6 (84/151)a

Overall (95 % CI)

67.3 (62.0 – 72.5)

67.7 (61.8 – 73.6)

Per patient

Per Protocol N = 231

Intent to treat N = 271

Per Protocol N = 182

Intent to treat N = 199

Salmanpour R [13]

67.8 (14/20)

75 (15/20)a

Layegh P [10]

58.3 (21/36)

52.5 (21/40)

27.8 (10/36)a

25.6 (10/39)a

López P [20]

37.9 (25/66)

28.4 (25/88)

94.8 (73/77)a

81.1 (73/90) a

Negera E [14]

93.3 (83/89)

80.6 (83/103)

89.5 (17/19)b

85.0 (17/20)b

Soto J [13]

20 (4/20)

70 (21/30)a

Overall % (95 % CI)

63.6 (57.2 – 70.1)

54.2 (48.0 – 60.4)

74.7 (68.1 – 81.3)

68.3 (61.6 – 75.1)

  1. aIntralesional meglumine antimonial (Glucantime® or generic)
  2. bSodium stibogluconate (Pentostam® or generic)